What they do
Acorai develops a handheld, non-invasive medical device that measures intracardiac pressure using machine learning and proprietary sensor technologies. Clinical teams use the device to assess congestion and adjust medication for heart failure patients in hospital settings.
The record
- Vertical
- Cardiovascular
- Sub-segment
- Heart failure management
- Product type
- Device
- Stage
- Seed
- Headquarters
- Helsingborg, Sweden
- Region
- Europe
- Founded
- 2019
- Total funding
- $5M raised
Notable investors: Solas BioVentures, Carma Fund, Sweden Innovation, Supermoon Capital.